BioCorRx Q1 Revenue Plummets, Assets Stand at $2.2M
Ticker: BICX · Form: 10-Q · Filed: May 15, 2025 · CIK: 1443863
| Field | Detail |
|---|---|
| Company | Biocorrx Inc. (BICX) |
| Form Type | 10-Q |
| Filed Date | May 15, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: revenue-decline, financials, preferred-stock, reporting
TL;DR
BioCorRx Q1 revenue CRASHED to $61k from $2.1M last year. Assets $2.2M.
AI Summary
BioCorRx Inc. filed its 10-Q for the period ending March 31, 2025. The company reported $61,638 in revenue for the three months ended March 31, 2025, a significant increase from $2,133,620 in the same period of 2024. Total assets were $2,211,980 as of March 31, 2025. Management owns 30,000 shares of Series A Preferred Stock, each convertible into one share of common stock and carrying 1,000 votes.
Why It Matters
The drastic drop in revenue suggests significant challenges for BioCorRx Inc. in the first quarter of 2025, potentially impacting its financial stability and future operations.
Risk Assessment
Risk Level: high — The substantial decrease in revenue from $2,133,620 to $61,638 year-over-year indicates a severe business downturn, posing a high risk to the company's financial health.
Key Numbers
- $61,638 — Q1 2025 Revenue (Significant decrease from Q1 2024)
- $2,133,620 — Q1 2024 Revenue (Prior year comparison point)
- $2,211,980 — Total Assets (As of March 31, 2025)
- 30,000 — Series A Preferred Shares (Owned by management, convertible and with voting rights)
Key Players & Entities
- BioCorRx Inc. (company) — Filer of the 10-Q
- March 31, 2025 (date) — End of reporting period
- $61,638 (dollar_amount) — Revenue for Q1 2025
- $2,133,620 (dollar_amount) — Revenue for Q1 2024
- $2,211,980 (dollar_amount) — Total assets as of March 31, 2025
- 30,000 (dollar_amount) — Shares of Series A Preferred Stock owned by management
FAQ
What caused the dramatic decrease in revenue for BioCorRx Inc. in Q1 2025?
The filing does not explicitly state the cause for the revenue decrease from $2,133,620 in Q1 2024 to $61,638 in Q1 2025.
What is the total value of assets for BioCorRx Inc. as of March 31, 2025?
As of March 31, 2025, BioCorRx Inc. reported total assets of $2,211,980.
What are the voting rights associated with the Series A Preferred Stock?
Each share of Series A Preferred Stock is entitled to one thousand (1,000) votes.
How many shares of Series A Preferred Stock are held by management?
Management owns 30,000 shares of Series A Preferred Stock.
Is the Series A Preferred Stock entitled to dividends?
No, the Series A Preferred Stock is not entitled to dividends.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding BioCorRx Inc. (BICX).